Model Integration and Configuration for siRNA Nucleic Acid

Characteristics of siRNA Nucleic Acid Drug Data

siRNA nucleic acid drug data originates primarily from preclinical research reports, clinical trial data, patent literature, drug regulatory approvals, and academic journals. This data updates infrequently, typically aligning with research and development progress and approval cycles. Document structures are predominantly unstructured text, such as research reports, patent specifications, and clinical trial protocols. However, structured data is also present, including compound structures, target information, dosage data, and pharmacokinetic parameters. Fields and units are highly specialized, for example, "IC50 value (nM)", "Kd value (nM)", "PK curve area (AUC, ng·h/mL)", "half-life (t1/2, hours)", and "off-target effect score". Additionally, sequence data (e.g., siRNA sequences, mRNA target sequences) forms a core component.

Constraints on Model Integration and Configuration from Data Characteristics

The specialized and diverse nature of siRNA nucleic acid drug data imposes specific requirements on model integration and configuration. The high proportion of unstructured text necessitates robust text parsing capabilities and deep semantic understanding to accurately extract key information. The presence of structured and sequence data requires the data preprocessing stage to identify and correctly handle different data types, such as encoding sequence data into vector representations understandable by the model. The low update frequency allows for greater resource allocation during initial data cleaning and model training, ensuring a high-quality baseline model. Highly specialized fields and units demand that the model accurately cites and explains these technical terms in its responses, preventing misinterpretation. For instance, the model must differentiate IC50 values under various assay conditions and understand their significance in drug activity assessment.

Configuration Guidelines

Configuration Item	Suggested Value	Rationale
`maxContext`	`16384 tokens`	siRNA nucleic acid drug development documents are often lengthy, requiring a larger context window to capture complete information.
`Chunk size` (Segment Length)	`800–1000 characters`	Balances semantic completeness with model processing efficiency, preventing excessively long paragraphs from diluting key information.
`Recall count` (Recall Count)	`Top 10 entries` (Top 10)	Nucleic acid drug information is dense; increasing the recall count helps cover more potentially relevant document segments.
`Similarity threshold` (Similarity Threshold)	`0.78`	Ensures semantic relevance of recalled content and filters out distracting information. This value requires fine-tuning with actual data.
`Rerank result count` (Rerank Return Count)	`5 entries` (5 items)	Based on a higher recall count, reranking selects the most relevant few segments for model generation.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Processing large PDF clinical reports and patent files requires a longer parsing time.

Three Common Mistakes

A "channel unavailable" message after saving model configurations typically indicates incorrect configuration of critical authentication information like OPENAI_API_KEY or CUSTOM_MODEL_URL, or a failed test for the corresponding channel in One API.
Model responses citing irrelevant technical terms or values, such as referencing small molecule drug PK parameters when discussing siRNA efficacy, occurs due to an inappropriate segmentation strategy leading to context confusion, or insufficient discriminative ability for technical terms during model training.
After uploading large patent files or clinical reports, prolonged unresponsiveness or failure in file parsing may result from UPLOAD_FILE_MAX_SIZE or PARSE_FILE_TIMEOUT_SECONDS being set too low, preventing the file from being processed within the allotted time.

How to Verify Configuration

Upload an siRNA preclinical report containing IC50 values and PK data. Check if the model accurately extracts and reiterates key numerical values and units.
For a patent file with complex siRNA sequences, ask questions about sequence design principles. Verify if the model's response correctly cites sequence fragments and explains their function.
In the FastGPT interface, use the "Test" function to confirm that the configured large model channel status is "Available" and that response speed is acceptable.
Through multiple queries, verify the consistency of the model's understanding and application of specialized terms like "off-target effect" and "delivery system" in different contexts. Cross-reference the accuracy of cited sources.

Note: The values provided are common starting points. Measure them against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.